Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentclathrin-coated endocytic vesicle

EPS15 CD4 EGF MYO6 CD74

1.69e-05101665GO:0045334
GeneOntologyCellularComponentclathrin-coated vesicle membrane

EPS15 CD4 EGF MYO6 CD74

1.02e-04147665GO:0030665
GeneOntologyCellularComponentclathrin-coated endocytic vesicle membrane

EPS15 CD4 EGF CD74

1.14e-0479664GO:0030669
GeneOntologyCellularComponentcoated vesicle membrane

EPS15 CD4 EGF MYO6 CD74

5.90e-04215665GO:0030662
GeneOntologyCellularComponentclathrin-coated vesicle

EPS15 CD4 EGF MYO6 CD74

9.14e-04237665GO:0030136
GeneOntologyCellularComponentcoated vesicle

EPS15 CD4 EGF MYO6 CD74 F8

9.53e-04360666GO:0030135
DomainAbhydrolase_1

ABHD12B LIPF

4.89e-0331632PF00561
DomainAB_hydrolase_1

ABHD12B LIPF

5.53e-0333632IPR000073
DomainMyosin_head_motor_dom

MYO6 MYO7B

7.28e-0338632IPR001609
DomainMYOSIN_MOTOR

MYO6 MYO7B

7.28e-0338632PS51456
DomainMyosin_head

MYO6 MYO7B

7.28e-0338632PF00063
DomainMYSc

MYO6 MYO7B

7.28e-0338632SM00242
Domain-

EGF APMAP

7.66e-03396322.120.10.30
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

VRK2 UPF2 MYO6 MTHFD1L SYNE1 PDCD11 DYNC2I1 PDZD8 RNF213 ANKMY2 CRYBG3 RTN1 ELAC2 MFN1

8.05e-071496671432877691
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

EPS15 VRK2 SGPL1 MID1 UBAP1 DYNC2I1 PDZD8 RNF213 PLCH1 RTN1

1.37e-06733671034672954
Pubmed

Molecular basis of oligoubiquitin-dependent internalization of membrane proteins in Mammalian cells.

EPS15 CD4

3.66e-06267216497223
Pubmed

CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.

CD4 CD74

3.66e-06267221555577
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

EPS15 VRK2 CLCN7 MYO6 MTHFD1L SYNE1 BAG3 PDCD11 PDZD8 CRYBG3 PLCH1 ATP2B4 ELAC2

4.45e-061487671333957083
Pubmed

Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study.

GRK5 BAG3

1.10e-05367229514624
Pubmed

Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions.

CD4 CD74

1.10e-05367219327048
Pubmed

Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.

CD4 CD74

1.10e-05367216439540
Pubmed

Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.

EPS15 TCAF1 ACAD11 SGPL1 BAG3

1.53e-0516167536398662
Pubmed

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

VSTM4 UPF2 SGPL1 GRK5 BAG3 LIPF PDZD8

1.54e-0541567716385451
Pubmed

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.

TCAF1 ACAD11 COG7 SGPL1 MID1 BAG3

1.81e-0528367621903422
Pubmed

K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.

EPS15 TCAF1 ACAD11 MYO6 BAG3 UBAP1 RNF213 TDP1

2.09e-0560467838803224
Pubmed

Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.

CD4 CD74

2.19e-05467216365153
Pubmed

Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.

CD4 CD74

2.19e-05467221157037
Pubmed

SGIP1alpha is an endocytic protein that directly interacts with phospholipids and Eps15.

EPS15 EGF

2.19e-05467217626015
Pubmed

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells.

CD4 CD74

2.19e-05467215322158
Pubmed

Attenuation of multiple Nef functions in HIV-1 elite controllers.

CD4 CD74

3.64e-05567223289738
Pubmed

Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.

CD4 CD74

3.64e-05567220463068
Pubmed

Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development.

EGF SOS2

3.64e-0556729030684
Pubmed

Viral channel proteins in intracellular protein-protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV.

CD4 CD74

3.64e-05567224035804
Pubmed

SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

EPS15 EGF

5.46e-05667219880507
Pubmed

The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses.

CD4 CD74

5.46e-05667221068258
Pubmed

Tails of unconventional myosins.

MYO6 MYO7B

7.63e-05767211212352
Pubmed

Defining the membrane proteome of NK cells.

EPS15 CLCN7 MYO6 MTHFD1L APMAP PDZD8 RNF213 CD74 MCTP2 ATP2B4

7.65e-051168671019946888
Pubmed

The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.

EPS15 CLCN7 MYO6 ATP2B4

1.02e-0412567429467281
Pubmed

Mapping of ornithine aminotransferase gene sequences to mouse chromosomes 7, X, and 3.

EGF F8

1.63e-04106721349842
Pubmed

CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection.

CD4 CD74

1.63e-041067224942581
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

EPS15 ELFN1 MTHFD1L SGPL1 APC2 DYNC2I1

1.82e-0443067632581705
Pubmed

Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

EPS15 EGF

1.99e-041167215962011
Pubmed

Role of Nef in primate lentiviral immunopathogenesis.

CD4 CD74

1.99e-041167218438604
Pubmed

TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling.

CD4 F8

2.38e-041267238053332
Pubmed

Viremic long-term nonprogressive HIV-1 infection is not associated with abnormalities in known Nef functions.

CD4 CD74

2.38e-041267224495362
Pubmed

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system.

APBA2 MCTP2

2.38e-041267224009623
Pubmed

Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.

EPS15 EGF

2.81e-041367212218189
Pubmed

FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.

VRK2 UFSP2 CLCN7 SGPL1 PDZD8 RTN1

2.87e-0446867631056421
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYO6 MYO7B

3.28e-04146728022818
Pubmed

A human MAP kinase interactome.

VRK2 MYO6 SYNE1 BAG3 MAP3K21 SOS2

3.51e-0448667620936779
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TCAF1 MYO6 SGPL1 RNF213 ALPK1 PLCH1

3.78e-0449367615368895
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

EPS15 MYO6 APMAP PDZD8 CRYBG3 PLCH1 MAP3K21

4.24e-0470867739231216
Pubmed

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.

COG7 SGPL1 RNF213 SOS2

4.39e-0418367423956138
Pubmed

Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

CD4 CD74

4.88e-041767215194762
Pubmed

The activity of Nef on HIV-1 infectivity.

CD4 CD74

4.88e-041767224904546
Pubmed

The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines.

EGF UBAP1 CD74

5.43e-048267325260751
Pubmed

The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module.

EPS15 EGF

5.48e-041867210567358
Pubmed

T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling.

CD4 CD74

5.48e-041867219723499
Pubmed

Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.

EGF SOS2

5.48e-041867219531499
Pubmed

G-protein-coupled receptor-mediated activation of rap GTPases: characterization of a novel Galphai regulated pathway.

EGF SOS2

5.48e-041867214712229
Pubmed

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.

CD4 PLCH1

5.48e-04186721979339
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

EPS15 MYO6 COG7 MTHFD1L SGPL1 APMAP

7.37e-0456067635241646
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

MYO6 SYNE1 APC2 APBA2 DYNC2I1 PDZD8 CD74 SYNGAP1 SOS2

7.77e-04128567935914814
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

CLCN7 SYNE1 PDCD11 RNF213

7.89e-0421467422199357
Pubmed

Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.

EPS15 MYO6

8.24e-042267226950368
Pubmed

Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy.

EPS15 MYO6 MFN1

9.39e-049967329676259
Pubmed

Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

INTU SGPL1 SYNE1

1.05e-0310367310574462
Pubmed

Screening the proteins that interact with calpain in a human heart cDNA library using a yeast two-hybrid system.

UFSP2 SYNE1

1.07e-032567212358155
Pubmed

In Vitro Identification of Histatin 5 Salivary Complexes.

PLCH1 F8

1.24e-032767226544073
Pubmed

Interactions of viral protein U (Vpu) with cellular factors.

CD4 CD74

1.24e-032767220012522
Pubmed

ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.

LCORL SYNE1 ELAC2

1.38e-0311367334474245
Pubmed

The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development.

ETV1 ATP2B4

1.54e-033067239366945
Pubmed

Modelling thymic HIV-1 Nef effects.

CD4 CD74

1.54e-033067216454711
Pubmed

Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice.

MYO6 RCAN2

1.54e-033067228077597
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

ACAD11 UPF2 SGPL1 MID1 CRYBG3 PLCH1

1.58e-0365067638777146
Pubmed

Global proteomics of Ubqln2-based murine models of ALS.

EPS15 TCAF1 FAM222B UBAP1

1.64e-0326167433277362
Pubmed

Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

CD4 CD74

1.64e-033167221922073
Pubmed

STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.

EPS15 BAG3

1.64e-033167228089446
Pubmed

Genetic variations in humans associated with differences in the course of hepatitis C.

CD4 EGF

1.75e-033267215063762
Pubmed

Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.

EGF SOS2

1.86e-033367218271526
GeneFamilyPDZ domain containing

INTU APBA2 PDZD8

4.27e-031523931220
ToppCellCOVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class

MYO6 APMAP SYNE1 APBA2 CD74 KIR3DL2 MCTP2 RCAN2

4.40e-10195658d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCellControl-CD8+_Tem|Control / Disease condition and Cell class

EPS15 MYO6 APMAP SYNE1 RNF213 CD74 ATP2B4

1.45e-081956577503b3e032f95b350a2782d28e4d412a8dc9ebcc
ToppCellCOVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class

MYO6 APMAP SYNE1 RNF213 CD74 ATP2B4 RCAN2

1.45e-08195657ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCellSevere-Lymphoid-NK-NK|Severe / Condition, Lineage, Cell class and cell subclass

APMAP SYNE1 WIPF3 APBA2 KIR3DL2 MCTP2 ATP2B4

1.56e-08197657d5b94f9f73e9d050245841b19b046242a32c6258
ToppCellsevere_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2)

MYO6 APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

1.61e-081986577f51e37516f717e424190e6584f1c74d357e2da4
ToppCellHealthy_donor-NK|World / disease group, cell group and cell class (v2)

MYO6 APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

1.61e-081986574c9c40e91173836ad0df2eba635a4cb3385e80c6
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

3.74e-07192656fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCellnormal_Pleural_Fluid-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass

EPS15 CD4 ETV1 RNF213 CD74 ATP2B4

3.98e-07194656cf2480cc40f3c9be837b3934547e2ce30bd4fcd3
ToppCellCOVID-19_Severe-CD8+_Tem|World / disease group, cell group and cell class

MYO6 APMAP SYNE1 APBA2 RNF213 RCAN2

3.98e-0719465660aa16e166894e3fcd82f7a54607c2c02e55b614
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP SYNE1 CD74 KIR3DL2 MCTP2 ATP2B4

3.98e-0719465652e09b14159b609af00264a8f38accf37ba8f464
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYO6 APMAP SYNE1 KIR3DL2 MCTP2 ATP2B4

4.10e-071956560b50b5c71a4949f3f8fb9f5c30f9d50f53ca050d
ToppCellCOVID-19_Severe-NK|World / disease group, cell group and cell class

APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

4.22e-07196656f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-071976562b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656e70e7d97823a762def3970d94a0e897981a6c922
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP SYNE1 APBA2 RNF213 KIR3DL2 ATP2B4

4.35e-0719765632b770e403028862f91e4727f4a8fbb6151910e4
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYO6 APMAP SYNE1 KIR3DL2 MCTP2 ATP2B4

4.35e-071976562abe27f6722fa0dab801bca4cd19e34c1fb4173e
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCellCOVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.35e-07197656d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.48e-07198656a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCellSevere-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass

APMAP SYNE1 WIPF3 KIR3DL2 MCTP2 ATP2B4

4.48e-0719865626b6d20527d22ce68067cdaea6b4330cb779f91b
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.48e-0719865676aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.48e-07198656a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCellsevere_COVID-19-NK|World / disease group, cell group and cell class (v2)

APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

4.48e-0719865636b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.48e-07198656df399674345c45738d765a8354ea8d1484572c34
ToppCellCOVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.48e-071986566aea5d00c417708f05b6d2dfe5a962d80864f8eb
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-071996564820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCellHealthy/Control-NK|World / Disease group and Cell class

MYO6 APMAP SYNE1 APBA2 KIR3DL2 MCTP2

4.62e-0719965687af9c38938dc2db0f9cf9f3676895d2a8b5d7e6
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-07199656eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-0719965610c8729b779073c3bf808e85958d59147f0be5c5
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-07199656867fd292f3879982422e840e087bfdb3b21a8715
ToppCellHealthy/Control-NK|Healthy/Control / Disease group and Cell class

APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

4.62e-07199656e7fd91080fca7c31a2d48433791da3c2a4adf14d
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-071996565e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCellControl-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-0719965694b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCellPBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.62e-07199656d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCellHealthy_donor-NK|Healthy_donor / disease group, cell group and cell class (v2)

APMAP SYNE1 APBA2 RNF213 KIR3DL2 MCTP2

4.62e-071996564892d85f7c8c00e5afdcea2cd7bae0074322fa52
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class

MYO6 APMAP SYNE1 RNF213 KIR3DL2 ATP2B4

4.75e-072006566560753d3df2f87860b52052d4881aa45410f666
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class

MYO6 APMAP SYNE1 RNF213 ATP2B4 RCAN2

4.75e-0720065631859b8db7ea17e48b7b54e92f0d76aeb755e7ca
ToppCellControl-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2 ATP2B4

4.75e-07200656c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

APMAP SYNE1 WIPF3 APBA2 KIR3DL2

5.14e-06171655adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYO6 APMAP SYNE1 RNF213 ATP2B4

5.91e-061766555914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ACAD11 MYO6 APMAP APBA2 KIR3DL2

6.96e-061826559d727ab84da8de33f1021b492c90d8b4c2a8ea23
ToppCellCOVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class

MYO6 SYNE1 RNF213 KIR3DL2 ATP2B4

7.14e-06183655f593a89b0aa8fffdfa403769916facfd30358521
ToppCell10x5'v1-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

VSTM4 MYO6 SNX7 MID1 RCAN2

7.73e-06186655fbc4ba4a7a8e5902a1b0add52ece0d6da85a8a5f
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

APMAP SYNE1 APBA2 RNF213 MCTP2

7.73e-06186655165d02be3b3eaeb8784a2b0b2020928b21a19bc7
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYO6 MTHFD1L ETV1 PLCH1 MCTP2

7.73e-06186655acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

7.93e-061876550bca79cea4886b66350c56c61859bd71e1e7a85c
ToppCellCOPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class

MYO6 SYNE1 CD74 RTN1 ATP2B4

8.14e-061886551aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP GRK5 RNF213 KIR3DL2 MCTP2

8.14e-061886559abd78970bbe4ed03b59a83da63bbd334712f605
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP GRK5 RNF213 KIR3DL2 MCTP2

8.14e-06188655f7dc29dfec68236883469e848be5db34f5526d6b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP GRK5 RNF213 KIR3DL2 MCTP2

8.14e-061886555ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1
ToppCellCOPD-Lymphoid-NK|World / Disease state, Lineage and Cell class

SYNE1 GRK5 APBA2 KIR3DL2 MCTP2

8.35e-06189655c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell(1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

MYO6 APMAP APBA2 KIR3DL2 MCTP2

8.57e-06190655268772d2adff34f7175b8474e95b67fd96dc1234
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue

MYO6 APMAP SYNE1 RNF213 ATP2B4

8.57e-0619065566d29f53f129fc18771f6214316a913eeaccd55e
ToppCellIPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class

APMAP SYNE1 APBA2 KIR3DL2 MCTP2

8.79e-06191655f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP SYNE1 KIR3DL2 MCTP2 ATP2B4

9.24e-0619365554604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8
ToppCellCOPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class

APMAP SYNE1 APBA2 KIR3DL2 MCTP2

9.24e-061936550020249fa71afb500af73700543bb6f349be6b10
ToppCell3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue

APMAP SYNE1 APBA2 KIR3DL2 MCTP2

9.24e-06193655a98ee519e0da93ae4a2dcdda1ee8b4138dec131b
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

9.48e-06194655a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 ATP2B4

9.48e-06194655e72be6dc2711c1d4f16943c8615cf9dc2e961ff3
ToppCell3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

APMAP SYNE1 APBA2 KIR3DL2 MCTP2

9.48e-061946553337042eef91a49f621058785723228cf4dfdad4
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 RNF213 ATP2B4

9.48e-06194655ac03be73fdc32dacd4a450c0fb28617e043b8444
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 RNF213 ATP2B4

9.48e-061946557ab4418a8a12c488d74af3676bdac672628da80c
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

9.48e-061946550abca32c3547a45cebab0bd69c1f7a0002deaa80
ToppCell3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

9.48e-061946557773501e076d470158dbc1d7f10c67152b326eb7
ToppCellPBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 RNF213 ATP2B4

9.48e-06194655760761ce7d22edf9a8cec71e8ab0caa273fce3f7
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

9.72e-06195655ed41e709523cc3b86b1090d4fc0938ed47cb1fc9
ToppCellhealthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

MYO6 APMAP SYNE1 RNF213 ATP2B4

9.96e-06196655af00c31612e4fe068e5fccae05368edba46bbd20
ToppCellsevere-CD8+_Tem|severe / disease stage, cell group and cell class

MYO6 APMAP SYNE1 APBA2 RNF213

9.96e-061966559456a5879948e25bc483a7233c274da841ef2c68
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO6 APMAP SYNE1 APBA2 RNF213

9.96e-061966550f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO6 APMAP SYNE1 APBA2 RNF213

9.96e-061966554e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCellCOVID-19_Severe-CD8+_Tem|COVID-19_Severe / disease group, cell group and cell class

MYO6 APMAP SYNE1 APBA2 RCAN2

9.96e-061966551bc1ec3351319c5d2daa0808cf161a7327e1758e
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

VSTM4 INTU SYNE1 DYNC2I1 ALPK1

1.02e-05197655fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.02e-051976554e141dfb094e10383d815fc7108b11a0584c3a4b
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.02e-0519765508286770c0b707a7a4436ea8d4416ddfbfe2dc0c
ToppCellInfluenza_Severe-NK|Influenza_Severe / Disease group and Cell class

MYO6 APMAP SYNE1 APBA2 KIR3DL2

1.02e-05197655d0f58ee4c02573d214deb210bb7efd3d6118f267
ToppCellsevere_influenza-NK|World / disease group, cell group and cell class (v2)

MYO6 APMAP SYNE1 APBA2 KIR3DL2

1.02e-051976558e86a1ee0418e153d4f0bf291006cffc6cf36f71
ToppCellCOVID-19_Severe-NK_activated|World / disease group, cell group and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.02e-05197655a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCellhealthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

APMAP SYNE1 RNF213 MCTP2 ATP2B4

1.05e-05198655d7053a898e04478c577381085f615edaad3cdc5b
ToppCellCOVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class

MYO6 APMAP SYNE1 RNF213 RCAN2

1.05e-051986551d12be256af028c88e31fb535068bae16b7bd48e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

APMAP SYNE1 CD74 KIR3DL2 ATP2B4

1.05e-05198655faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0
ToppCellmild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

APMAP SYNE1 KIR3DL2 MCTP2 ATP2B4

1.05e-051986551e43181c13e054570046c7a973ddc1c586e259b0
ToppCell5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SNX7 APC2 ETV1 RTN1 RCAN2

1.05e-05198655b58138581f1a9073267d64c1211c5b9b4de71d3e
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD4 APMAP SYNE1 MCTP2 ATP2B4

1.05e-05198655a6b942fe850e287e1cb705684e29218072daf891
ToppCellCV|World / Virus stimulation, Condition and Cluster

SYNE1 RNF213 CD74 ATP2B4 SPSB3

1.05e-051986556a28193af35abec5c029129930c2ca6febaafde2
ToppCellCD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

SYNE1 RNF213 CD74 ATP2B4 SPSB3

1.05e-051986553d1749f5106f0912f4a74615863853949f52c73d
ToppCellremission-NK|World / disease stage, cell group and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.05e-05198655383ed78164ad37826100d3de6c3cc14f62e01813
ToppCellURO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type

APMAP SYNE1 APBA2 RNF213 KIR3DL2

1.05e-051986552ccff882aafabf041df15b31d9abc50dcbc2696e
ToppCellhealthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass

APMAP SYNE1 RNF213 MCTP2 ATP2B4

1.05e-05198655aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655fd3706f256e33cf348774bea0ba0df6d41fd96e3
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655252f0084fa17770f4c34e21066519d7f7cad75d9
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655e981b159841222a6838effff1059c683c20ecf5b
ToppCellCOVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-051996558cdd5aa30a8112b77f5d02b40c45b63f541e1476
ToppCellCOVID-19_Convalescent-Lymphoid_T/NK-NK|COVID-19_Convalescent / Disease group, lineage and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-051996559809d996a2c3f5384707646a3929e1d6b85dcdc2
ToppCellCOVID-19_Moderate-NK|World / disease group, cell group and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655c41b67b760831c7d5e19fabcc932a056dc560f93
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-05199655a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc
ToppCellremission-NK|remission / disease stage, cell group and cell class

APMAP SYNE1 RNF213 KIR3DL2 MCTP2

1.07e-0519965531ed2a314e8f70980ea0686242446d66929288e9
DiseaseEpithelioid Cell Uveal Melanoma

VRK2 TDP1

2.52e-0411642EFO_1000244
DiseaseHydrops Fetalis

SGPL1 SOS2

7.73e-0419642C0020305
DiseaseColorectal Carcinoma

DPAGT1 VSTM4 MTHFD1L SYNE1 APC2 ETV1 MFN1

8.03e-04702647C0009402
DiseaseCharcot-Marie-Tooth disease (implicated_via_orthology)

SGPL1 MFN1

1.24e-0324642DOID:10595 (implicated_via_orthology)
Diseasecorneal topography

INTU LCORL WIPF3

1.73e-03109643EFO_0004345

Protein segments in the cluster

PeptideGeneStartEntry
LKVTIPPFHDPLKKA

FAM228B

146

P0C875
HLKAEAELPPKLPLQ

C16orf86

121

Q6ZW13
PPLVLLSEPLAAKHG

ELFN1

596

P0C7U0
ALELALHAGKLPFPP

COG7

651

P83436
QLEPLGINEPPHLLK

CRYBG3

2656

Q68DQ2
GINEPPHLLKAFSKP

CRYBG3

2661

Q68DQ2
SIKPPLLHLDLKPGN

ANKK1

136

Q8NFD2
NLLKTIPNHQPGKPL

COQ3

131

Q9NZJ6
PFLVDLKKPELKIPH

ABHD12B

81

Q7Z5M8
PKSLNLLPEAKHPGD

APBA2

281

Q99767
SFKEPPLLLGVLHPN

APMAP

71

Q9HDC9
ALFTRHKPLNPPIKK

C2orf73

271

Q8N5S3
HQPDKKGVPRDFILP

MTHFD1L

916

Q6UB35
GHNVIPPKKPKTFLE

ATP2B4

81

P23634
KKPPGSLLPKAHQID

ACAD11

71

Q709F0
AKGLHKLQPATPIAP

ALPK1

131

Q96QP1
DKLHLAPPQPAKQFL

RCAN2

96

Q14206
GEFKFLKPIIPNLLP

PCDHB5

761

Q9Y5E4
HRKPSLLAHPGPLLK

KIR3DL2

121

P43630
KPLLPAGIQDKLHTL

MFN1

481

Q8IWA4
DKPPDFLGKVAIPLL

MCTP2

581

Q6DN12
KHPDKVDLTVPLPFL

ERVS71-1

251

P61550
VFHLDPPVKKLLVSP

KIAA2026

2036

Q5HYC2
KTLLLHLEALPAGKP

LCORL

306

Q8N3X6
FLGLLALPLAPHKQP

BPIFA3

11

Q9BQP9
APKLFKPQQHGIRPV

DYNC2I1

896

Q8WVS4
PHPFPKEIPHNEKLL

CLCN7

76

P51798
VPKPFRPILGLHLDL

DPAGT1

151

Q9H3H5
VGLLLPKLPNLIYHK

LIPF

351

P07098
LNRKLAVGSHPLPPK

PDZD8

541

Q8NEN9
FHGLPLKIKKEPHSP

ETV1

81

P50549
LAQSFHLKPPLEKPT

FAM222B

416

Q8WU58
PKGVKHLKDFPILPG

F8

511

P00451
PNPFHLGNLKKDLPE

INTU

766

Q9ULD6
PLPQEKLPGKSFKHD

CCNYL3

56

P0C7X3
KPLPPLRHLDGLAQD

APC2

756

O95996
PLGELKVVHPLAQPK

EGF

291

P01133
KKLPLHLTLPQALPQ

CD4

276

P01730
LPPKLAGPLHKIITT

ANKMY2

156

Q8IV38
QKLIKGIDPPHVLTP

EPS15

291

P42566
PPLKGSFPENLRHLK

CD74

156

P04233
HPPEPPKKGLLQRLF

GRK5

541

P34947
PPKHPGVLKVEAILE

BAG3

416

O95817
AIPLHLKSQLRKGPP

UPF2

1141

Q9HAU5
GAPPPLLFLNKQKAI

RTN1

576

Q16799
LLPHLLPALGFKNKT

MRPL36

56

Q9P0J6
NPLLLPVDKIHPSLK

SOS2

101

Q07890
IEHPLQPQPGLKEKF

SYNE1

2756

Q8NF91
PIGVHPSLAPLAKIL

TCAF1

91

Q9Y4C2
PDGLEHRKPKQIKLP

MAP3K21

651

Q5TCX8
ALLHIFSGKPPEKPL

FAM90A26

116

D6RGX4
KAVKPQLAPLHLPPI

WIPF3

246

A6NGB9
LEGLPLPPGLKQVLH

SPSB3

296

Q6PJ21
KGKLEEAHPTLIIPP

SNX7

81

Q9UNH6
NPLHPDIFPGLRKIE

SGPL1

171

O95470
PEPLHFLLPGKKNLV

UFSP2

196

Q9NUQ7
KPPVRDPKGFLQQHI

RNF213

4606

Q63HN8
QPLKDLLHLPELFSP

PDCD11

131

Q14690
PPEFRKKPILLVHGD

TDP1

216

Q9NUW8
KPLHKPNGFITLPQL

UBAP1

226

Q9NZ09
NLFLHQGRPPKLPKG

ARHGAP40

431

Q5TG30
PKLIPPLKALFAGDI

ELAC2

761

Q9BQ52
PQLSKEALLKLGPLP

SYNGAP1

701

Q96PV0
PNKKPFTGHRLIEPI

MID1

151

O15344
PVPKQLAHLPLPALK

PLCH1

1471

Q4KWH8
IAPTFHKPKLLKPQR

VSTM4

261

Q8IW00
KPLQLPPIFLEGEKG

C16orf82

66

Q7Z2V1
KILNPHGIPLGPLDF

VRK2

311

Q86Y07
ELHPDKPPILLVAGK

MYO6

1216

Q9UM54
FPPSKGLLPHAQKFI

MYO7B

1741

Q6PIF6